On February 15, 2019, Stealth Biotherapeutics, the company founded by Dr. Hazel Szeto, a WCM Pharmacology professor, ~ 12 years ago, priced its IPO today of 6.5M ADSs, each representing 12 ordinary shares of Stealth, at a price of $12.00/ADS, for expected gross proceeds of $78M.